Bibliometric insight into neoadjuvant immunotherapy in non-small cell lung cancer: trends, collaborations, and future avenues
BackgroundNeoadjuvant immunotherapy (NIT) is a rapidly emerging paradigm for advanced resectable non-small cell lung cancer (NSCLC). However, there is no bibliometric analysis in this research field.ObjectiveTo analyze the hotspots and trends in the research of NIT for NSCLC and provide a reference...
Saved in:
Main Authors: | Pengliang Xu, Huanming Yu, Hupo Bian, Dan Jia, Wenhui Li, Hongfeng Dong, Xiuhua Peng |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1533651/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Opportunities and challenges of immuno-oncology: A bibliometric analysis from 2014 to 2023
by: Siqi Zhang, et al.
Published: (2025-12-01) -
Bibliometric analysis of ferroptosis: a comprehensive evaluation of its contribution to lung cancer
by: Feifei Yao, et al.
Published: (2025-01-01) -
Prognostic Impact of Adjuvant Immunotherapy in Patients With Resectable NSCLC After Neoadjuvant Chemoimmunotherapy: A Brief Report
by: Yichen Dong, MD, et al.
Published: (2025-01-01) -
Global visualization of adolescent idiopathic scoliosis treatment: a bibliometric analysis
by: Xiaodong Zheng, et al.
Published: (2025-02-01) -
Comparative efficacy and safety of first-line neoadjuvant therapy for early-stage non-small cell lung cancer based on immune checkpoint inhibitor therapy: a systematic review and network meta-analysis
by: Linfeng Wang, et al.
Published: (2025-01-01)